Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders

Ryumachi

Volumn 43, Issue 1, 2003, Pages 19-28

  Ogawa, Noriyoshi ^a   Shimoyama, Kumiko ^a   Kawabata, Hiroshi ^a   Masaki, Yasufumi ^a   Wano, Yuji ^a   Sugai, Susumu ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Ga scintigraphy; High resolution computed tomography (HRCT); Interstitial pneumonia; KL 6; SP D

Indexed keywords

BIOCHEMICAL MARKER; GALLIUM; LACTATE DEHYDROGENASE; PROTEIN KL 6; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BEHCET DISEASE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DERMATOMYOSITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERSTITIAL LUNG DISEASE; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; POLYMYOSITIS; RHEUMATOID ARTHRITIS; SCINTIGRAPHY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VALIDATION PROCESS; VASCULITIS;

ANTIGENS; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; COLLAGEN DISEASES; FEMALE; GLYCOPROTEINS; HUMANS; L-LACTATE DEHYDROGENASE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MUCINS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; SENSITIVITY AND SPECIFICITY;

EID: 0037302204     PISSN: 03009157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Nobuyuki K: Serum marker KL-6/MUC 1 for the diagnosis and management of interstitial pneumonia. J Med Invest 46: 151-158, 1999
2. Takahashi H, Fujishima T, Koba H et al: Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 162: 1109-1114, 2000
3. Asano Y, Ihn H, Yamane K et al: Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. Arthritis Rheum 44: 1363-1369, 2001
4. Fukaya S, Oshima H, Komatsu Y et al: KL-6 as a novel marker for activities of interstitial pneumonia in connective tissue diseases. Rheumatol Int 19: 223-225, 2000
5. Yoshitama T, Yamaguchi A, Izumihara T et al: Comparative evaluation of KL-6 and surfactant protein D as serum markers for interstitial pneumonia associated with collagen diseases. Mod Rheumatol 11: 121-126, 2001
6. Hamada H, Kohno N, Yokoyama A et al: KL-6 as a serologic indicator of pneumocystis carinii pneumonia in immunocompromised hosts. Intern Med 37: 307-310, 1997
7. Nakajima H, Harigai M, Hara M et al: KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. J Rheumatol 27: 1164-1170, 2000
8. Kajiume T, Yoshimi S, Nagita A: A case of myelodysplastic syndrome complicated by pulmonary proteinosis with a high serum KL-6 level. Pediatr Hematol Oncol 16: 367-371, 1999
9. Takahashi H, Kuroki Y, Honda Y et al: Lipid analysis and surfactant-associated protein expression in lung adenocarcinoma cells from pleural effusion. Respiration 63: 390-396, 1996